Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease

PurposeSubthalamic deep brain stimulation (STN-DBS) is a well-established intervention for advanced Parkinson's disease (PD). Routine neuroimaging can be used to estimate location and volume of activated tissue (VTA), by modeling the type of stimulator and stimulation parameters. We aimed here at developing a strategy based on clinical brain MRI scans to predict motor and non-motor outcomes of STN-DBS. Materials and methodsWe included 25 consecutive patients with advanced PD eligible for STN-DBS. At baseline, patients underwent a comprehensive motor and cognitive/behavioral assessment, and conventional MRI. They underwent STN-DBS surgery, followed by a CT scan. Patients were reassessed 1 year later, while STN-DBS was active. Their neuroimaging data were used to calculate individual VTAs. The voxel-lesion-symptom-mapping (VLSM) toolbox, which allows to associate clinical variables with brain features of interest, was used to investigate associations between changes (in either direction) of motor, cognitive/behavioral scores between baseline and follow-up, and VTA subregions. Six newly enrolled patients were used to test the predictive value of this approach at a single subject level. ResultsVLSM analysis (p values corrected for multiple comparisons < 0.05) identified specific VTA subclusters associated with improved bradykinesia, verbal fluency, and mood state, and some others associated with worsening of tremor, long-term memory, and apathy. When considering cognitive/behavioral changes, an effect of hemisphere lateralization was observed, with modulation of the right basal ganglia being associated with symptoms' worsening, and left-side modulation associated with improvements. VTA subclusters predictive for clinical changes were mostly located outside the STN, indicating the importance of networks over single nuclei simulation. ConclusionThis approach suggests a possible way to personalize surgical planning, DBS-implant choice, and stimulation programing in the framework of precision medicine.